Publications by authors named "Nada Babovic"

Claim this Profile
C
Circulating IL-6 is associated with disease progression in BRAFwt metastatic melanoma patients receiving anti-PD-1 therapy.
Katarina Mirjačić Martinović, Ana Vuletić, Nevena Tišma Miletić, Suzana Matković, Dušica Gavrilović

J Clin Pathol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased circulating monocyte MDSCs positively correlate with serum Interleukin-10 in metastatic melanoma patients.
Katarina Mirjačić Martinović, Ana Vuletić, Nevena Tišma Miletić, Milica Nedeljković, Nada Babović

Innate Immun· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased circulating TGF-β1 is associated with impairment in NK cell effector functions in metastatic melanoma patients.
Katarina Mirjačić Martinović, Ana Vuletić, Emina Mališić, Tatjana Srdić-Rajić, Nevena Tišma Miletić

Growth Factors· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real World Overall Survival of Patients With Metastatic Renal Cell Carcinoma Treated With Only Available Sunitinib and Pazopanib in First-Line Setting.
Predrag Nikic, Nada Babovic, Zoran Dzamic, Svetlana Salma, Vesna Stojanovic

Front Oncol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-4-induced natural killer cell antitumor activity in metastatic melanoma patients.
Ana M Vuletić, Gordana M Konjević, Annette K Larsen, Nada L Babović, Vladimir B Jurišić

Eur Cytokine Netw· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AROME-ESO Oncology Consensus Conference: access to cancer care innovations in countries with limited resources. Association of Radiotherapy and Oncology of the Mediterranean Area (AROME-Paris) and European School of Oncology (ESO - Milan).
Vladimir Todorovic, Matti Aapro, Nicholas Pavlidis, Oliver Arsovski, Yazid Belkacemi, Nada Babovic

J BUON· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the Functional Capacity of NK Cells of Melanoma Patients in an In Vitro Model of NK Cell Contact with K562 and FemX Tumor Cell Lines.
Gordana Konjevic, Ana Vuletic, Katarina Mirjacic Martinovic, Ana Krivokuca, Radmila Jankovic, Nada Babovic

J Membr Biol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beneficial in-vitro effects of interleukin-2, interleukin-12, and their combination on functional and receptor characteristics of natural killer cells in metastatic melanoma patients with normal serum lactate dehydrogenase levels.
Katarina M Mirjačić Martinović, Nada Lj Babović, Radan R Džodić, Vladimir B Jurišić, Aleksandra Z Ninković

Melanoma Res· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decreased expression of pSTAT, IRF-1 and DAP10 signalling molecules in peripheral blood lymphocytes of patients with metastatic melanoma.
Katarina Mirjačić Martinović, Tatjana Srdić-Rajić, Nada Babović, Radan Džodić, Vladimir Jurišić

J Clin Pathol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ombrabulin plus cisplatin versus placebo plus cisplatin in patients with advanced soft-tissue sarcomas after failure of anthracycline and ifosfamide chemotherapy: a randomised, double-blind, placebo-controlled, phase 3 trial.
Jean-Yves Blay, Zsuzsanna Pápai, Anthony W Tolcher, Antoine Italiano, Didier Cupissol, Nada Babovic

Lancet Oncol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Favorable in vitro effects of combined IL-12 and IL-18 treatment on NK cell cytotoxicity and CD25 receptor expression in metastatic melanoma patients.
Katarina Mirjačić Martinović, Nada Babović, Radan Džodić, Vladimir Jurišić, Suzana Matković

J Transl Med· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicopathological characteristics, diagnosis and treatment of melanoma in Serbia--the Melanoma Focus Study.
Lidija Kandolf-Sekulović, Nada Babović, Neven Jokić, Borislava Nikolin, Dejan Nikolić

Vojnosanit Pregl· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decreased expression of NKG2D, NKp46, DNAM-1 receptors, and intracellular perforin and STAT-1 effector molecules in NK cells and their dim and bright subsets in metastatic melanoma patients.
Katarina M Mirjačić Martinović, Nada Lj Babović, Radan R Džodić, Vladimir B Jurišić, Nikola T Tanić

Melanoma Res· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The stage dependent changes in NK cell activity and the expression of activating and inhibitory NK cell receptors in melanoma patients.
Katarina Mirjačić Martinović, Gordana Konjević, Nada Babović, Momčilo Inić

J Surg Res· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In-vitro IL-2 or IFN-α-induced NKG2D and CD161 NK cell receptor expression indicates novel aspects of NK cell activation in metastatic melanoma patients.
Gordana Konjević, Katarina Mirjačić Martinović, Ana Vuletić, Nada Babović

Melanoma Res· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarkers of suppressed natural killer (NK) cell function in metastatic melanoma: decreased NKG2D and increased CD158a receptors on CD3-CD16+ NK cells.
Gordana Konjević, Katarina Mirjacić Martinović, Vladimir Jurisić, Nada Babović, Ivan Spuzić

Biomarkers· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular targeting agents in renal cell carcinoma: present strategies and future perspectives.
Snezana K Bjelogrlic, Sinisa Radulovic, Nada Babovic

Curr Pharm Des· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low expression of CD161 and NKG2D activating NK receptor is associated with impaired NK cell cytotoxicity in metastatic melanoma patients.
Gordana Konjević, Katarina Mirjacić Martinović, Ana Vuletić, Viktor Jović, Vladimir Jurisić

Clin Exp Metastasis· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis